How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Topic
Trends & Insights
GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
AI trends shaping healthcare in 2026: agentic, physical & sovereign AI
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
Understanding the breast cancer patient journey in 2025
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
GLP-1 trends 2025: real-world data, patient outcomes & future therapies
Few areas of medicine have captured public interest over the past two years quite like...
Building better AI mortality models with Verified data
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
The GLP-1 trend: What the real-world data reveals
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
What everyone’s missing about data quality for AI and FDA readiness
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
The biomarker advantage
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
Unlocking AI Success: Lessons from the HealthVerity and AWS Webinar
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...